GLAXO - IntraDay Trade Analysis

Last Updated Time : 02 Aug 25, 12:58 am

📉 Intraday Trade Analysis – GlaxoSmithKline Pharmaceuticals (GLAXO) IntraDay Trade Rating: 2.6

While GLAXO shows excellent long-term fundamentals (stellar ROCE/ROE and low debt), its current technical setup is relatively weak for intraday trading. The muted RSI, negative MACD, and proximity to resistance suggest limited upside and potential stagnation for day traders.

🔍 Technical Snapshot

RSI (46.0) → Neutral range, signaling lack of strong momentum.

MACD (-33.0) → Bearish crossover territory; hints at potential short-term decline.

Volume (1.01L vs Avg 81K) → Slight spike in activity, but not aggressive.

Price hugging DMA50 (₹3,158) → Reflects indecision around short-term trend.

Negative PEG Ratio (-3.11) → Suggests overvaluation despite earnings growth.

💸 Intraday Trade Setup

📌 Trade Component Suggested Levels (₹)

Buy Zone ₹3,145 – ₹3,150

Profit Target ₹3,168 – ₹3,180

Stop-Loss Level Below ₹3,135

🎯 Consider entry only if there’s a green breakout candle above ₹3,150 and volume surpasses 1.2L early in the session. Risk-reward here is mild.

⏱ If You're Already Holding Today

Profit-Taking Signals

Exit if price nears ₹3,175 with flat RSI and no volume surge.

Slight uptick in MACD toward neutral could offer a brief scalp exit.

Loss-Protecting Signals

Exit below ₹3,135 if MACD continues trending down and RSI falls below 44.

Declining volume and resistance near ₹3,158 make this zone fragile.

🧠 Final Thought

GLAXO isn't a standout intraday candidate today. It’s trading in a consolidation range with low directional bias. If you're looking for sharper moves and momentum setups, you might want to explore other pharma or mid-cap stocks.

Want me to scan the sector for better trade setups today? I can pull in names with high RSI, MACD crossovers, and solid volumes. Let me know!

Edit in a page